Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19)
1 other identifier
observational
417
1 country
1
Brief Summary
Multicenter retrospective chart review of patients admitted to any of the four Methodist Health System hospitals
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 30, 2020
CompletedFirst Submitted
Initial submission to the registry
September 22, 2020
CompletedFirst Posted
Study publicly available on registry
September 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 23, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 23, 2022
CompletedMarch 23, 2026
May 1, 2022
2 years
September 22, 2020
March 19, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of subsequent and co-infections
Prevalence of subsequent and co-infections
Feb 2020 - April 2020
Secondary Outcomes (2)
In-hospital mortality
Feb 2020 - April 2020
Hospital length of stay (LOS)
Feb 2020 - April 2020
Study Arms (1)
Retrospective Cohort
Patients admitted to Methodist Richardson, Methodist Mansfield, Methodist Charlton, or Methodist Dallas Medical Centers between February 1, 2020 and April 30, 2020 with positive COVID-19 PCR test.
Interventions
Eligibility Criteria
Adult patients with positive COVID-19 PCR test admitted to Methodist Richardson, Methodist Mansfield, Methodist Charlton, or Methodist Dallas Medical Centers between February 1, 2020 and April 30, 2020.
You may qualify if:
- Patients admitted to Methodist Richardson, Methodist Mansfield, Methodist Charlton, or Methodist Dallas Medical Centers between February 1, 2020 and April 30, 2020
- \>18 years old
- Positive SARS-CoV-2 (COVID-19) PCR test
You may not qualify if:
- Outpatient or emergency department visit
- Not admitted to an inpatient or observation status for \>24 hours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Methodist Dallas Medical Center
Dallas, Texas, 75203, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew Crotty, PharmD
Methodist Health System
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 22, 2020
First Posted
September 23, 2020
Study Start
May 30, 2020
Primary Completion
May 23, 2022
Study Completion
May 23, 2022
Last Updated
March 23, 2026
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share